Revenue Recognition and Accounts Receivable (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of composition of net revenues by payor type and core service lines

The composition of net revenue by payor type for the three and nine months ended September 30, 2023 and 2022 are as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Insurance	$	486,136	$	465,625	$	1,397,748	$	1,322,694
Government	220,351		198,841		618,860		576,829
Patient pay	97,544		92,029		325,335		290,789
Net revenue	$	804,031	$	756,495	$	2,341,943	$	2,190,312

The composition of net revenue by core product lines for the three and nine months ended September 30, 2023 and 2022 are as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Net sales revenue:
Sleep	$	227,005	$	198,206	$	656,311	$	585,234
Diabetes	157,328		169,075		464,893		482,693
Supplies to the home	48,349		47,793		143,227		131,539
Respiratory	8,164		9,734		24,284		25,770
HME	27,095		29,463		82,895		89,828
Other	64,184		58,252		174,403		166,068
Total net sales revenue	$	532,125	$	512,523	$	1,546,013	$	1,481,132
Net revenue from fixed monthly equipment reimbursements:
Sleep	$	88,387	$	72,423	$	256,092	$	196,022
Diabetes	2,609		4,211		10,326		12,191
Respiratory	142,919		130,618		423,531		392,063
HME	25,087		25,482		71,402		76,754
Other	12,904		11,238		34,579		32,150
Total net revenue from fixed monthly equipment reimbursements	$	271,906	$	243,972	$	795,930	$	709,180
Total net revenue:
Sleep	$	315,392	$	270,629	$	912,403	$	781,256
Diabetes	159,937		173,286		475,219		494,884
Supplies to the home	48,349		47,793		143,227		131,539
Respiratory	151,083		140,352		447,815		417,833
HME	52,182		54,945		154,297		166,582
Other	77,088		69,490		208,982		198,218
Total net revenue	$	804,031	$	756,495	$	2,341,943	$	2,190,312